全文获取类型
收费全文 | 607篇 |
免费 | 28篇 |
国内免费 | 23篇 |
专业分类
耳鼻咽喉 | 1篇 |
儿科学 | 29篇 |
妇产科学 | 9篇 |
基础医学 | 61篇 |
口腔科学 | 9篇 |
临床医学 | 63篇 |
内科学 | 116篇 |
皮肤病学 | 3篇 |
神经病学 | 18篇 |
特种医学 | 186篇 |
外科学 | 41篇 |
综合类 | 3篇 |
预防医学 | 24篇 |
眼科学 | 8篇 |
药学 | 55篇 |
肿瘤学 | 32篇 |
出版年
2021年 | 7篇 |
2018年 | 4篇 |
2015年 | 2篇 |
2014年 | 5篇 |
2013年 | 14篇 |
2012年 | 7篇 |
2011年 | 8篇 |
2010年 | 13篇 |
2009年 | 9篇 |
2008年 | 12篇 |
2007年 | 29篇 |
2006年 | 14篇 |
2005年 | 16篇 |
2004年 | 14篇 |
2003年 | 7篇 |
2002年 | 5篇 |
2001年 | 13篇 |
2000年 | 10篇 |
1999年 | 6篇 |
1998年 | 32篇 |
1997年 | 46篇 |
1996年 | 26篇 |
1995年 | 27篇 |
1994年 | 19篇 |
1993年 | 13篇 |
1992年 | 7篇 |
1991年 | 10篇 |
1990年 | 18篇 |
1989年 | 23篇 |
1988年 | 30篇 |
1987年 | 19篇 |
1986年 | 23篇 |
1985年 | 23篇 |
1984年 | 11篇 |
1983年 | 10篇 |
1982年 | 17篇 |
1981年 | 11篇 |
1980年 | 19篇 |
1979年 | 7篇 |
1978年 | 7篇 |
1977年 | 9篇 |
1976年 | 14篇 |
1975年 | 5篇 |
1974年 | 2篇 |
1973年 | 2篇 |
1971年 | 2篇 |
1970年 | 2篇 |
1968年 | 3篇 |
1967年 | 4篇 |
1966年 | 3篇 |
排序方式: 共有658条查询结果,搜索用时 15 毫秒
1.
2.
Marjan Boerma Gregory R Burton Junru Wang Louis M Fink Robert E McGehee Martin Hauer-Jensen 《Blood coagulation & fibrinolysis》2006,17(3):173-180
Immortalized cell lines offer significant logistical advantages over primary cells when used for in-vitro studies. Immortalized cells may, however, exhibit important differences relative to their primary cell counterparts. In this study, microarrays were used to make a genome-wide comparison between primary human umbilical vein endothelial cells (HUVECs) and EA.hy926, an immortalized HUVEC cell line, in their baseline properties and in their response to inhibition of the mevalonate pathway with an inhibitor of hydroxy methylglutaryl-coenzyme A reductase (statin). HUVECs and EA.hy926 were incubated with control medium, atorvastatin, mevalonate, or a combination of atorvastatin and mevalonate for 24 h. Gene expression profiles were obtained in duplicates using Affymetrix Human Genome U133A 2.0 arrays (Santa Clara, California, USA). Probe-sets were selected according to the following criteria: a twofold or greater increase/decrease in atorvastatin-treated cells compared with untreated cells; a twofold or greater reversal of the effect of atorvastatin by combined treatment with atorvastatin and mevalonate; no significant change in gene expression in cells treated with mevalonate alone compared with untreated cells. Most genes that were expressed by untreated HUVECs, were also expressed by untreated EA.hy926 cells. EA.hy926 cells, however, constitutively expressed a large number of additional genes, many of which were related to cell cycle control and apoptosis. Atorvastatin induced differential expression (> or = twofold) of 103 genes in HUVECs (10 up, 93 down) and 466 genes in EA.hy926 cells (198 up, 268 down). Applying the above selection criteria, thrombomodulin and tissue plasminogen activator were up-regulated in both cell types, whereas, connective tissue growth factor, thrombospondin-1, and cysteine-rich angiogenic inducer 61 were down-regulated. In conclusion, EA.hy926 cells retain most of the characteristics of endothelial cells under baseline conditions as well as after treatment with atorvastatin. It is necessary, however, to carefully select and validate changes in genes that are the focus of studies when using EA.hy926 cells. While this cell line is highly useful in studies on some genes, including genes encoding molecules involved in regulating thrombohemorrhagic homeostasis, they appear to be less suited for studies focused on other genes, particularly those involved in the regulation of cell proliferation and apoptosis. 相似文献
3.
Golli M; Van Nhieu JT; Mathieu D; Zafrani ES; Cherqui D; Dhumeaux D; Vasile N; Rahmouni A 《Radiology》1994,190(3):741
4.
5.
MGC Hendriks P Dogterom JT Ebels B Oosterhuis LR Geertsema T Hulot G Bianchetti and JHG Jonkman 《Fundamental & clinical pharmacology》1998,12(5):559-565
Summary— In the present study we have compared the steady state biopharmaceutic characteristics of four diltiazem once daily controlled release capsules: Mono-Tildiem LP 300® (300 mg), Adizem® XL (300 mg)1, Cardizem® (300 mg) and Dilacor® (240 mg). Sixteen healthy male volunteers (aged 22.9 ± 3.3 years, range 19–31 years) completed an open label, multiple oral dose, randomized, four-period crossover study without a washout period in between. The volunteers received each diltiazem formulation once daily for four days. Trough diltiazem and metabolites plasma concentrations were determined on days 3 and 4. The 24-h plasma concentration-time profiles were assessed after the dose on day 4 of each period. The following steady state pharmacokinetic parameters for diltiazem were calculated: the minimum plasma concentration (cmin), the maximum plasma concentration (cmax), the time to reach that concentration (tmax), the time interval during which the plasma concentration exceeds 50% of cmax (t50), the area under the plasma concentration-time curve (AUC72–96) and the peak-to-trough fluctuation (PTF). For the metabolites of diltiazem, N-mono-desmethyl-diltiazem (NDM) and desacetyldiltiazem (DAD), AUC72–96 (AUCNDM and AUCDAD) and the ratio metabolite/parent compound were calculated. Steady state was achieved on day 3. Except one, all controlled release formulations have satisfactory controlled release properties allowing once daily administration. However, significant (P < 0.05) differences were found between the pharmacokinetic characteristics which do not allow exchange of the various formulations. Concentrations well below 50 ng·mL-1 in the morning hours were observed for Dilacor® (240 mg) and Adizem® XL (300 mg), which could be a disadvantage of these formulations as it is well-known that ischaemic events occur at a higher rate during that part of the day. The plasma concentration profiles of NDM and DAD, the major circulating metabolites, parallel the plasma concentration profiles for the parent compound. From a clinical point of view, all treatments were well tolerated. 相似文献
6.
Steve H Murdock Md Nazrul Hoque Kenneth Johnson Mary A McGehee 《The Journal of rural health》2003,19(4):425-432
The diversification of the rural population of the United States provides substantial challenges to the current and to future health care systems in rural areas. Because of a variety of historical, discriminatory, and other factors, minority populations have had lower levels of access to health care in rural as well as urban areas and higher rates of both mortality and morbidity than nonminority populations. Although minority health issues have often been seen as primarily urban issues, this article demonstrates that minority population growth has become a major component of total population growth in rural areas in the past several decades (accounting for nearly 62% of the net growth in the nonmetropolitan population of the United States in the 1980s and for nearly 42% in the 1990s), that future US population growth is likely to be largely a product of minority population growth (nearly 89% of US net population growth from 2000 to 2100 is projected to be due to minority population growth), and that the incidence of diseases and disorders in the US population will come to increasingly involve minority populations (by 2050 roughly 43% of all disease/disorder incidences would involve minority population members). The growth of younger minority populations with disproportionately impoverished socioeconomic characteristics will pose challenges for rural areas and health care systems, which also are likely to face health issues created by disproportionately older populations. 相似文献
7.
Intestinal obstruction proximal to a transition zone without an interposed physical barrier usually indicates Hirschsprung disease. The authors report one case of focal small bowel muscular thinning just distal to a transition zone that produced clinical and radiographic findings that simulated long-segment Hirschsprung disease in a 2-day-old infant. 相似文献
8.
Development of hatching blastocysts from immature human oocytes following in-vitro maturation and fertilization using a co-culture system 总被引:8,自引:0,他引:8
Hwu YM; Lee RK; Chen CP; Su JT; Chen YW; Lin SP 《Human reproduction (Oxford, England)》1998,13(7):1916-1921
Recently, in-vitro maturation (IVM) of immature human oocytes recovered
from non-stimulated follicles has been applied in the treatment of
infertility. However, in previous reports, very few embryos cultured in
conventional medium have reached the expanded blastocyst stage following
in-vitro maturation and fertilization (IVM/IVF). The objective of this
study was to investigate whether the developmental competence of human
embryos following IVM/IVF could be enhanced by the use of a human ampullary
cell co-culture system. Immature human oocytes were aspirated from small
follicles at Caesarean section and then cultured in medium containing human
menopausal gonadotrophin for 36 to 48 h, followed by insemination. Zygotes
were randomly cultured either in conventional culture medium alone or in
the co-culture system. Of 48 embryos cultured in conventional medium alone,
all arrested at the 2-16- cell stage on day 3 after insemination. Of 46
embryos cultured in the co-culture system, 26 embryos (56.5%) arrested at
the 2-16-cell stage. Six embryos (13%) developed to the morula stage.
Fourteen embryos (30.4%) developed to expanded blastocysts and two
blastocysts were hatching on day 7 after insemination. We conclude that
co-culture significantly enhances the development of blastocysts in embryos
resulting from IVM/IVF.
相似文献
9.
The ratio of 2nd to 4th digit length: a predictor of sperm numbers and concentrations of testosterone, luteinizing hormone and oestrogen 总被引:19,自引:2,他引:19
Manning JT; Scutt D; Wilson J; Lewis-Jones DI 《Human reproduction (Oxford, England)》1998,13(11):3000-3004
The differentiation of the urinogenital system and the appendicular
skeleton in vertebrates is under the control of Hox genes. The common
control of digit and gonad differentiation raises the possibility that
patterns of digit formation may relate to spermatogenesis and hormonal
concentrations. This work was concerned with the ratio between the length
of the 2nd and 4th digit (2D:4D) in humans. We showed that (i) 2D:4D in
right and left hands has a sexually dimorphic pattern; in males mean 2D:4D
= 0.98, i.e. the 4th digit tended to be longer than the 2nd and in females
mean 2D:4D = 1.00, i.e. the 2nd and 4th digits tended to be of equal
length. The dimorphism is present from at least age 2 years and 2D:4D is
probably established in utero; (ii) high 2D:4D ratio in right hands was
associated with germ cell failure in men (P = 0.04); (iii) sperm number was
negatively related to 2D:4D in the right hand (P = 0.004); (iv) in men
testosterone concentrations were negatively related to right hand 2D:4D and
in women and men LH (right hand), oestrogen (right and left hands) and
prolactin (right hand) concentrations were positively correlated with 2D:4D
ratio and (v) 2D:4D ratio in right hands remained positively related to
luteinizing hormone and oestrogen after controlling for sex, age, height
and weight.
相似文献
10.